312
Views
6
CrossRef citations to date
0
Altmetric
Review

Novel diagnostic tools and solutions for multiple sclerosis treatment: a patent review (2009 – 2014)

&
 

Abstract

Introduction: With > 2 million people affected by multiple sclerosis (MS) worldwide, the elucidation of its etiopathogenesis is of highest interest. Ongoing research in medicine, molecular biology, chemistry and physics aims to improve the life of MS patients by increasing efficacy and decreasing adverse side effects of presently available drugs. A precise diagnosis of this complex disease, which can take different courses, is fundamental to finding an efficient treatment strategy.

Areas covered: We present a summary of diagnostic and therapeutic patents granted between 2009 and 2014. Diagnostic inventions use both genetic and proteomic approaches or measure cerebral venous hemodynamics. Instead, new treatments rely on small molecules and/or the active manipulation of proteins that are involved in the pathogenesis of MS.

Expert opinion: There are some promising approaches among recently published patents. In particular, genetic profiling for diagnosis, combination of novel drugs with FDA-approved drugs to reduce side effects, and the personalisation of MS treatments according to a more defined diagnosis are considered as important. In the light of the latest developments, we discuss the complex picture of MS, which we assume to be different events connected by a causal chain consisting of circulatory abnormalities, altered redox processes in CNS immune cells, oligodendropathy, inflammation and finally autoimmunity.

Declaration of interest

E König was supported by the Marie Curie Fellowship (PITN-GA-2012-317297). The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

Notes

This box summarizes key points contained in the article.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.